Assessment of dynamic susceptibility contrast cerebral blood flow response to amphetamine challenge: A human pharmacological magnetic resonance imaging study at 1.5 and 4 T
✍ Scribed by Stephen E. Rose; Andrew L. Janke; Mark W. Strudwick; Katie L. McMahon; Jonathan B. Chalk; Peter Snyder; Greig I. De zubicaray
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 393 KB
- Volume
- 55
- Category
- Article
- ISSN
- 0740-3194
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Pharmacological MRI (phMRI) techniques can be used to monitor the neurophysiological effects of central nervous system (CNS) active drugs. In this study, we investigated whether dynamic susceptibility contrast (DSC) perfusion imaging employing the use of superparamagnetic iron oxide nanoparticles (Resovist) could be used to measure hemodynamic response to d‐amphetamine challenge in human subjects at both 1.5 and 4 T. Significant changes in cerebral blood flow (CBF) were found in focal regions associated with the nigrostriatal circuit and mesolimbic and mesocortical dopaminergic pathways. More significant CBF responses were found at higher field strength, mainly within striatal structures. The results from this study indicate that DSC perfusion imaging using Resovist can be used to assess the efficacy of CNS‐active drugs and may play a role in the development of novel psychiatric therapies at the preclinical level. Magn Reson Med, 2006. © 2005 Wiley‐Liss, Inc.